<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The E6AP ubiquitin-protein ligase (E3) mediates the <z:e sem="disease" ids="C0850011,C0850009" disease_type="Disease or Syndrome" abbrv="">human papillomavirus</z:e>-induced degradation of the p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor in <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> and is mutated in <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e>, a <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological disorder</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The crystal structure of the catalytic hect domain of E6AP reveals a bilobal structure with a broad catalytic cleft at the junction of the two lobes </plain></SENT>
<SENT sid="2" pm="."><plain>The cleft consists of conserved residues whose mutation interferes with ubiquitin-<z:chebi fb="0" ids="51277">thioester</z:chebi> bond formation and is the site of <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> mutations </plain></SENT>
<SENT sid="3" pm="."><plain>The crystal structure of the E6AP hect domain bound to the UbcH7 ubiquitin-conjugating enzyme (E2) reveals the determinants of E2-E3 specificity and provides insights into the transfer of ubiquitin from the E2 to the E3 </plain></SENT>
</text></document>